ZA867494B - Antiinflammatory compositions and methods - Google Patents

Antiinflammatory compositions and methods

Info

Publication number
ZA867494B
ZA867494B ZA867494A ZA867494A ZA867494B ZA 867494 B ZA867494 B ZA 867494B ZA 867494 A ZA867494 A ZA 867494A ZA 867494 A ZA867494 A ZA 867494A ZA 867494 B ZA867494 B ZA 867494B
Authority
ZA
South Africa
Prior art keywords
methods
antiinflammatory
antiinflammatory compositions
pharmaceutically acceptable
acceptable salt
Prior art date
Application number
ZA867494A
Other languages
English (en)
Inventor
Thomas Charles Crawford
David Lee Larson
Joseph George Lombardino
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ZA867494B publication Critical patent/ZA867494B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
ZA867494A 1985-10-02 1986-10-01 Antiinflammatory compositions and methods ZA867494B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8501926 1985-10-02

Publications (1)

Publication Number Publication Date
ZA867494B true ZA867494B (en) 1988-05-25

Family

ID=22188870

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA867494A ZA867494B (en) 1985-10-02 1986-10-01 Antiinflammatory compositions and methods

Country Status (15)

Country Link
US (1) US4994457A (xx)
EP (1) EP0218453B1 (xx)
JP (1) JPS6296424A (xx)
KR (1) KR890001236B1 (xx)
AT (1) ATE49121T1 (xx)
AU (1) AU563822B2 (xx)
CA (1) CA1273875A (xx)
DE (1) DE3667914D1 (xx)
DK (1) DK166343C (xx)
GR (1) GR3000305T3 (xx)
HU (1) HU207219B (xx)
IE (1) IE58635B1 (xx)
NZ (1) NZ217778A (xx)
PT (1) PT83472B (xx)
ZA (1) ZA867494B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5436241A (en) * 1994-01-14 1995-07-25 Bristol-Myers Squibb Company Topical anti-inflammatory compositions containing piroxicam
US20070141181A1 (en) * 1998-02-13 2007-06-21 Nutramax Laboratories, Inc. Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals
US6797289B2 (en) 1998-02-13 2004-09-28 Nutramax Laboratories, Inc. Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals
US20010000472A1 (en) * 1998-02-27 2001-04-26 Nutramax Laboratories, Inc. L-ergothioneine, milk thistle, and s-adenosylmethionine for the prevention, treatment and repair of liver damage
AU3308999A (en) 1998-02-27 1999-09-15 Nutramax Laboratories, Inc. L-ergothioneine, milk thistle, and s-adenosylmethionine for the prevention, treatment and repair of liver damage
US20030099722A1 (en) * 2001-10-09 2003-05-29 Baxter Jeffrey H. Methods and compositions for providing glutamine
KR101153242B1 (ko) * 2004-09-17 2012-06-08 아지노모토 가부시키가이샤 기능성 소화관 장해 예방 또는 개선제 및 식품
KR101821050B1 (ko) 2015-10-14 2018-03-09 씨제이제일제당 (주) 바이오-기반 n-아세틸-l-메티오닌 및 이의 용도

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1029660A (en) * 1973-06-01 1978-04-18 Kyowa Hakko Kogyo Co. Prevention of gastric lesions
JPS5714589A (en) * 1980-06-27 1982-01-25 Mitsui Toatsu Chem Inc Benzothiazine derivative, its preparation and drug composition
GB2078738B (en) * 1980-06-27 1983-11-30 Mitsui Toatsu Chemicals Benzothiazine derivatives
US4434163A (en) * 1981-06-01 1984-02-28 Pfizer Inc. Water-soluble benzothiazine dioxide salts
US4434164A (en) * 1981-06-01 1984-02-28 Pfizer Inc. Crystalline benzothiazine dioxide salts
US4486436A (en) * 1982-07-22 1984-12-04 Analgesic Associates Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
US4551452A (en) * 1983-12-21 1985-11-05 Pfizer Inc. Anti-inflammatory 2-methyl-2H-1,2-benzo-(or -thieno-)thiazine-3-carboxamide 1,1-dioxide derivatives, compositions, and method of use therefor
US4579846A (en) * 1984-10-11 1986-04-01 Pfizer Inc. Antiinflammatory compositions and methods
ATE64096T1 (de) * 1984-10-11 1991-06-15 Pfizer Piroxicam enthaltende entzuendungshemmende zusammensetzungen.
US4559326A (en) * 1985-01-31 1985-12-17 Pfizer Inc. Antiinflammatory compositions and methods

Also Published As

Publication number Publication date
EP0218453A1 (en) 1987-04-15
GR3000305T3 (en) 1991-06-07
ATE49121T1 (de) 1990-01-15
DK468486D0 (da) 1986-10-01
HU207219B (en) 1993-03-29
CA1273875A (en) 1990-09-11
KR870003783A (ko) 1987-05-04
PT83472A (en) 1986-11-01
NZ217778A (en) 1989-03-29
HUT46216A (en) 1988-10-28
US4994457A (en) 1991-02-19
AU6342186A (en) 1987-04-09
JPS6296424A (ja) 1987-05-02
DK468486A (da) 1987-04-03
IE58635B1 (en) 1993-10-20
DK166343C (da) 1993-09-06
EP0218453B1 (en) 1990-01-03
KR890001236B1 (ko) 1989-04-28
DE3667914D1 (de) 1990-02-08
AU563822B2 (en) 1987-07-23
PT83472B (pt) 1989-05-31
JPH0470285B2 (xx) 1992-11-10
DK166343B (da) 1993-04-13
IE862599L (en) 1987-04-02

Similar Documents

Publication Publication Date Title
JPS6450858A (en) Manufacture of 2,2,6,6-tetramethyl-4- piperidylamine
ZA856905B (en) Expectorant
AU587648B2 (en) Process for the preparation of (2,2)- paracyclophane
AU4931985A (en) Pharmaceutical compositions of 1, 1-cyclobutane- dicarboxylatediammineplatinum (ii) and alpha-cyclodextrin
ZA867494B (en) Antiinflammatory compositions and methods
NZ223865A (en) 3'-azido or fluoro-2',3'-dideoxyribofuranosyl derivatives and pharmaceutical compositions therefrom
PT81933A (en) Process for preparing improved antiinflammatory compositions containing pyroxicam and inositol
AU569176B2 (en) Preparation of 2,4-dichloro-5-fluoro-benzoic acid
NZ212915A (en) 9-oxo-15-alpha-hydroxy-16-(substituted) phenoxy-17,18,19,20-tetranorprosta-4,5,13(e)-triene prostaglandins and pharmaceutical compositions
AU548640B2 (en) Preparation of 5,6,7,7alpha-tetrahydro-4h-thieno(3,2-c) pyridin-2-ones
IL87134A0 (en) Preparation of 1,2,4-triazol-3-ones
JPS6463542A (en) Manufacture of 3,3-dimethyl-4-pentenoic acid
AU1517788A (en) Analogs of (1,7-DI-Alanine, des-19-leucine)
JPS6416755A (en) Manufacture of n-(3',4'-dimethoxycinnamoyl)-aniline derivative
AU581956B2 (en) 6-chloro-3-methyl-1H-2,3,4,5-tetrahydro-3-benzazepine- N-oxide and medical compositions using it
AU557580B2 (en) 15-cycloaliphatic derivatives of 13,14-didehydro- carboprostacyclins
JPS6431739A (en) Manufacture of 2,4,6-trichlorophenol
IL85254A0 (en) 14,15-substituted lanosterols and pharmaceutical compositions containing them
NZ223138A (en) 2,1-benzothiazepine-2,2-dioxide-5-carboxylic acid derivatives and pharmaceutical compositions
AU4552489A (en) Amine salts of 1,4,2-oxazaphospholidine-4-acetic acid, 2-alkoxy-2-oxides
AU559498B2 (en) Production of 4:-demethyl-epipodophyllotoxin-beta-d- ethylidene-glucoside, and derivatives
ZA885123B (en) Pest-combating agents based on derivatives of 2,3-diaminomaleonitrile
ES8800666A1 (es) Procedimiento para la obtencion de derivados de 1,4-dihidropiridina
AU8146887A (en) N (halobenzoyl)n'(4-cf3-f-phenyl)- ureas & - thioureas
JPS6434938A (en) Manufacture of 2,4-dichloro-3-methyl-phenol